News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Reports of a preliminary U.S.-Iran ceasefire sent oil prices sharply lower.
  • Fiserv shares plunged about 7% after CEO Mike Lyons left to become Truist's CEO.
  • Nvidia plans to issue at least $20 billion of investment-grade bonds across seven maturities for corporate purposes.
  • Nuvei agreed to buy Payoneer for $2.75 billion cash, expanding its cross-border payments scale.
  • ASX accepted responsibility for misleading CHESS upgrade communications and agreed to a A$20.5 million penalty.
  • Strategy Inc. raised $209 million via ATM sales and bought 1,587 bitcoin, increasing its crypto holdings.
  • American Express will buy TheFork from Tripadvisor for $700 million to expand its global dining network.

Latest Articles

Forbright Raises $142.2 Million in Nasdaq IPO

Forbright Raises $142.2 Million in Nasdaq IPO

Forbright Inc. completed an initial public offering of 7.9 million Class A shares at $18.00 apiece, bringing in about $142.2 million in gross proceeds. The stock started trading on the Nasdaq Global Select Market under the symbol FRBT. Underwriters have a 30-day option to buy up to 1.185 million additional shares at the IPO price, subject to custom…

Avista pauses processing of energy service request from 500 MW data center developer while seeking broader policy and community alignment

Avista pauses processing of energy service request from 500 MW data center developer while seeking broader policy and community alignment

Avista Corp., a US energy company, has temporarily suspended processing the energy service request from a potential 500 MW data center developer amid community concerns and to seek broader alignment with governmental agencies and stakeholders. The company emphasizes the need for a coordinated planning process, regulatory approvals, and ensuring tha…

XOMA Royalty Corporation Declares Quarterly Preferred Stock Dividend and Announces Redemption of Its Perpetual Preferred Stock and CVR Dividend Record Date

XOMA Royalty Corporation Declares Quarterly Preferred Stock Dividend and Announces Redemption of Its Perpetual Preferred Stock and CVR Dividend Record Date

XOMA Royalty Corporation announced quarterly cash dividends for its Series A and Series B cumulative perpetual preferred stock, with payments scheduled for mid-July 2026. Furthermore, the company will redeem all outstanding preferred shares at $25 per share on July 14, 2026, ceasing dividend accrual thereafter. This redemption is in connection with…

Cartesian Therapeutics Announces New Employment Inducement Grant

Cartesian Therapeutics Announces New Employment Inducement Grant

Cartesian Therapeutics announced a new employment inducement award granting 6,100 stock options to a new employee at an exercise price matching the recent closing price. The options vest over four years with a ten-year term, approved by the board under Nasdaq inducement rules. The company specializes in late-stage clinical cell therapies targeting …

Monolithic Power Systems Announces Second Quarter 2026 Dividend

Monolithic Power Systems Announces Second Quarter 2026 Dividend

Monolithic Power Systems, a Nasdaq-listed semiconductor company, announced a quarterly dividend of $2.00 per share for Q2 2026, payable on July 15, 2026. This dividend declaration underscores the company's robust financial health and commitment to returning value to shareholders. MPS specializes in high-performance semiconductor power electronics w…

Rhythm Pharmaceuticals to Announce Interim Six-Month Phase 2 Results Evaluating Setmelanotide in Patients with Prader-Willi Syndrome

Rhythm Pharmaceuticals to Announce Interim Six-Month Phase 2 Results Evaluating Setmelanotide in Patients with Prader-Willi Syndrome

Rhythm Pharmaceuticals announced a live webcast and conference call to discuss interim six-month results from its Phase 2 clinical trial of setmelanotide in patients with Prader-Willi syndrome. Setmelanotide is an FDA-approved MC4R agonist currently used to treat various rare genetic and hypothalamic obesity disorders. The company is expanding clin…

Evercore Highlights Select P&C Insurers Poised to Withstand Margin Pressure

Evercore Highlights Select P&C Insurers Poised to Withstand Margin Pressure

Evercore analyst David Motemaden warns that property and casualty insurers and brokers face margin compression heading into the second half of 2026, with many carriers currently overearning and likely to see returns decline. Despite this backdrop, Motemaden identifies Aon, Arthur J. Gallagher & Co. and Progressive as names that could outperform, ci…

Village Super Market, Inc. Declares Quarterly Dividend

Village Super Market, Inc. Declares Quarterly Dividend

Village Super Market, Inc. declared quarterly dividends of $0.25 for Class A shares and $0.1625 for Class B shares, payable on July 23, 2026, to shareholders of record as of July 2, 2026. The company operates 34 supermarkets under ShopRite and Fairway banners and Gourmet Garage specialty markets across several states.

Seadrill Senior VP Wieggers Offloads Remaining Equity Stake in June Sale

Seadrill Senior VP Wieggers Offloads Remaining Equity Stake in June Sale

Marcel Wieggers, Senior Vice President of Operations at SEADRILL Ltd (NASDAQ: SDRL), executed a complete divestiture of his direct equity holdings in the company on June 11, 2026. The executive sold a total of 13,475 common shares, realizing proceeds of $605,566. This transaction, detailed in a Form 4 filing submitted to the Securities and Exchange…

Seadrill Executive Liquidates Entire Stake Following Recent Sales

Seadrill Executive Liquidates Entire Stake Following Recent Sales

Seadrill Ltd. executive Todd D. Strickler has completed a significant divestiture, selling his entire direct holding of the company's common stock. The SVP and General Counsel offloaded 31,409 shares on June 10, 2026, realizing approximately $1.4 million from the transaction. This sale concludes his direct equity ownership in the offshore drilling …

S&P Lowers Dye & Durham Rating as Leverage and Coverage Deteriorate

S&P Lowers Dye & Durham Rating as Leverage and Coverage Deteriorate

S&P Global Ratings cut Dye & Durham Corp.'s credit rating to CCC+ from B-, citing an unsustainable capital structure driven by rising adjusted leverage and weakening EBITDA interest coverage. The agency also placed a negative outlook on the company and lowered the issue-level rating on its secured debt, warning that the firm is increasingly reliant…

HRT Financial LP Fully Exits Aditxt Position Following $39,668 Share Sale

HRT Financial LP Fully Exits Aditxt Position Following $39,668 Share Sale

HRT FINANCIAL LP, which previously held a 10% ownership stake in Aditxt, Inc., executed a complete divestiture of its position by selling 2,833,463 shares of common stock on June 11, 2026. The transaction, valued at $39,668 based on a sale price of $0.014 per share, marks the total exit of the institutional investor from the biotech company. This s…

OP Bancorp COO Disposes of $309,928 in Common Stock Amid Dividend Increase

OP Bancorp COO Disposes of $309,928 in Common Stock Amid Dividend Increase

OP Bancorp (NASDAQ:OPBK) Chief Operating Officer Christine Oh executed a series of equity sales between June 10 and June 12, 2026, realizing a total of $309,928. The transactions occurred at weighted average prices ranging from $14.0836 to $14.2892 per share. This executive activity follows the company's announcement of a 17% increase in its quarte…

Cosmos Health Receives New Contract Manufacturing Orders Totaling 253,657 Units Across a Range of Medicines

Cosmos Health Receives New Contract Manufacturing Orders Totaling 253,657 Units Across a Range of Medicines

Cosmos Health Inc., a diversified global healthcare company listed on NASDAQ under ticker COSM, announced that its subsidiary Cana Laboratories has received new contract manufacturing orders totaling 253,657 units across multiple pharmaceutical products. These orders come from partners Nassington and Verisfield, highlighting demand for Cana's manuf…